메뉴 건너뛰기




Volumn 10, Issue 1, 2015, Pages

Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder

Author keywords

Access to care; Buprenorphine maintenance treatment; Incarceration; Opioid use disorder

Indexed keywords

BUPRENORPHINE;

EID: 84961551518     PISSN: 19400632     EISSN: 19400640     Source Type: Journal    
DOI: 10.1186/s13722-014-0023-0     Document Type: Article
Times cited : (73)

References (49)
  • 3
    • 79952490502 scopus 로고    scopus 로고
    • The health of prisoners
    • 21093904
    • Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377:956-65.
    • (2011) Lancet , vol.377 , pp. 956-965
    • Fazel, S.1    Baillargeon, J.2
  • 6
    • 58249087123 scopus 로고    scopus 로고
    • Treating drug abuse and addiction in the criminal justice system: Improving public health and safety
    • 1:CAS:528:DC%2BD1MXnsFGmsg%3D%3D 2681083 19141766
    • Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301:183-90.
    • (2009) JAMA , vol.301 , pp. 183-190
    • Chandler, R.K.1    Fletcher, B.W.2    Volkow, N.D.3
  • 7
    • 47549100230 scopus 로고    scopus 로고
    • A randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months post-release
    • 2582162 18855822
    • Gordon MS, Kinlock TW, Schwartz RP, O'Grady KE. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction. 2008;103:1333-42.
    • (2008) Addiction , vol.103 , pp. 1333-1342
    • Gordon, M.S.1    Kinlock, T.W.2    Schwartz, R.P.3    O'Grady, K.E.4
  • 8
    • 84887858809 scopus 로고    scopus 로고
    • Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009
    • 24189594
    • Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159:592-600.
    • (2013) Ann Intern Med , vol.159 , pp. 592-600
    • Binswanger, I.A.1    Blatchford, P.J.2    Mueller, S.R.3    Stern, M.F.4
  • 10
    • 44949167587 scopus 로고    scopus 로고
    • Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
    • Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;(2):CD002207.
    • (2008) Cochrane Database Syst Rev. , Issue.2 , pp. CD002207
    • Mattick, R.P.1    Kimber, J.2    Breen, C.3    Davoli, M.4
  • 11
    • 0031967641 scopus 로고    scopus 로고
    • The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis
    • 1:STN:280:DyaK1czkvFSitw%3D%3D 9684390
    • Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515-32.
    • (1998) Addiction , vol.93 , pp. 515-532
    • Marsch, L.A.1
  • 12
    • 69949089584 scopus 로고    scopus 로고
    • Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey
    • 1:CAS:528:DC%2BD1MXhtFajurjN 2743749 19625142
    • Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83-8.
    • (2009) Drug Alcohol Depend , vol.105 , pp. 83-88
    • Nunn, A.1    Zaller, N.2    Dickman, S.3    Trimbur, C.4    Nijhawan, A.5    Rich, J.D.6
  • 13
    • 23944496343 scopus 로고    scopus 로고
    • Attitudes and practices regarding the use of methadone in US state and federal prisons
    • 3456063 15917502
    • Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;82:411-9.
    • (2005) J Urban Health , vol.82 , pp. 411-419
    • Rich, J.D.1    Boutwell, A.E.2    Shield, D.C.3    Key, R.G.4    McKenzie, M.5    Clarke, J.G.6
  • 14
    • 84856867111 scopus 로고    scopus 로고
    • Opioid pharmacotherapy in criminal justice settings: Now is the time
    • 22263707
    • Lee JD, Rich JD. Opioid pharmacotherapy in criminal justice settings: now is the time. Subst Abus. 2012;33:1-4.
    • (2012) Subst Abus , vol.33 , pp. 1-4
    • Lee, J.D.1    Rich, J.D.2
  • 16
    • 27644483928 scopus 로고    scopus 로고
    • Substance use in prison: How much occurs and is it associated with psychopathology?
    • Simpler AH, Langhinrichsen-Rohling J. Substance use in prison: how much occurs and is it associated with psychopathology? Addiction Research & Theory. 2005;13:503-11.
    • (2005) Addiction Research & Theory , vol.13 , pp. 503-511
    • Simpler, A.H.1    Langhinrichsen-Rohling, J.2
  • 17
    • 0025815751 scopus 로고
    • Recent research on the relationship between illicit drug use and crime
    • Nurco DJ, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav Sci Law. 1991;9:221-42.
    • (1991) Behav Sci Law , vol.9 , pp. 221-242
    • Nurco, D.J.1    Hanlon, T.E.2    Kinlock, T.W.3
  • 18
    • 30344474620 scopus 로고    scopus 로고
    • Assessing released inmates for substance-abuse-related service needs
    • Belenko S. Assessing released inmates for substance-abuse-related service needs. Crime & Delinquency. 2006;52:94-113.
    • (2006) Crime & Delinquency , vol.52 , pp. 94-113
    • Belenko, S.1
  • 19
    • 20044362964 scopus 로고    scopus 로고
    • Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection
    • 15918812
    • Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 2005;100:820-8.
    • (2005) Addiction , vol.100 , pp. 820-828
    • Dolan, K.A.1    Shearer, J.2    White, B.3    Zhou, J.4    Kaldor, J.5    Wodak, A.D.6
  • 20
    • 68449100499 scopus 로고    scopus 로고
    • Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico
    • 1:CAS:528:DC%2BD2sXhtlOmtbjM 21768947
    • Garcia CA, Correa GC, Viver AD, Kinlock TW, Gordon MS, Avila CA, et al. Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico. J Addict Med. 2007;1:126-32.
    • (2007) J Addict Med , vol.1 , pp. 126-132
    • Garcia, C.A.1    Correa, G.C.2    Viver, A.D.3    Kinlock, T.W.4    Gordon, M.S.5    Avila, C.A.6
  • 21
    • 37349001803 scopus 로고    scopus 로고
    • A study of methadone maintenance for male prisoners: 3-month postrelease outcomes
    • 2443939 18612373
    • Kinlock TW, Gordon MS, Schwartz RP, O'Grady KE. A study of methadone maintenance for male prisoners: 3-month postrelease outcomes. Crim Justice Behav. 2008;35:34-47.
    • (2008) Crim Justice Behav , vol.35 , pp. 34-47
    • Kinlock, T.W.1    Gordon, M.S.2    Schwartz, R.P.3    O'Grady, K.E.4
  • 22
    • 57049126482 scopus 로고    scopus 로고
    • Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
    • 2658719 18930603
    • Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, et al. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend. 2009;99:222-30.
    • (2009) Drug Alcohol Depend , vol.99 , pp. 222-230
    • Magura, S.1    Lee, J.D.2    Hershberger, J.3    Joseph, H.4    Marsch, L.5    Shropshire, C.6
  • 23
    • 84905567370 scopus 로고    scopus 로고
    • A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry
    • 1:CAS:528:DC%2BC2cXhtVanu73P 24962326
    • Gordon MS, Kinlock TW, Schwartz RP, Fitzgerald TT, O'Grady KE, Vocci FJ. A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry. Drug Alcohol Depend. 2014;142:33-40.
    • (2014) Drug Alcohol Depend , vol.142 , pp. 33-40
    • Gordon, M.S.1    Kinlock, T.W.2    Schwartz, R.P.3    Fitzgerald, T.T.4    O'Grady, K.E.5    Vocci, F.J.6
  • 24
    • 55649122602 scopus 로고    scopus 로고
    • The effect of a jail methadone maintenance therapy (MMT) program on imate recidivism
    • 19469745
    • McMillan GP, Lapham S, Lackey M. The effect of a jail methadone maintenance therapy (MMT) program on imate recidivism. Addiction. 2008;103:2017-23.
    • (2008) Addiction , vol.103 , pp. 2017-2023
    • McMillan, G.P.1    Lapham, S.2    Lackey, M.3
  • 26
    • 33748181939 scopus 로고    scopus 로고
    • Community reentry: Perceptions of people with substance use problems returning home from New York City jails
    • 2527198 16739041
    • van Olphen J, Freudenberg N, Fortin P, Galea S. Community reentry: perceptions of people with substance use problems returning home from New York City jails. J Urban Health. 2006;83:372-81.
    • (2006) J Urban Health , vol.83 , pp. 372-381
    • Van Olphen, J.1    Freudenberg, N.2    Fortin, P.3    Galea, S.4
  • 27
    • 84873707047 scopus 로고    scopus 로고
    • Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors
    • 3414824 22966409
    • Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.
    • (2012) Addict Sci Clin Pract , vol.7 , pp. 3
    • Binswanger, I.A.1    Nowels, C.2    Corsi, K.F.3    Glanz, J.4    Long, J.5    Booth, R.E.6
  • 28
    • 80052521657 scopus 로고    scopus 로고
    • From the prison door right to the sidewalk, everything went downhill", a qualitative study of the health experiences of recently released inmates
    • 21802731
    • Binswanger IA, Nowels C, Corsi KF, Long J, Booth RE, Kutner J, et al. "From the prison door right to the sidewalk, everything went downhill", a qualitative study of the health experiences of recently released inmates. Int J Law Psychiatry. 2011;34:249-55.
    • (2011) Int J Law Psychiatry , vol.34 , pp. 249-255
    • Binswanger, I.A.1    Nowels, C.2    Corsi, K.F.3    Long, J.4    Booth, R.E.5    Kutner, J.6
  • 29
    • 0037987960 scopus 로고    scopus 로고
    • Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: Why the 4:1 ratio for treatment?
    • 1:CAS:528:DC%2BD3sXjsVWlu7w%3D 12738348
    • Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend. 2003;70:S29-37.
    • (2003) Drug Alcohol Depend , vol.70 , pp. S29-37
    • Mendelson, J.1    Jones, R.T.2
  • 30
    • 75849134168 scopus 로고    scopus 로고
    • Developing and implementing a new prison-based buprenorphine treatment program
    • 2868193 20473351
    • Kinlock TW, Gorden MS, Schwartz RP, Fitzgerald TT. Developing and implementing a new prison-based buprenorphine treatment program. J Offender Rehabil. 2010;49:91-109.
    • (2010) J Offender Rehabil , vol.49 , pp. 91-109
    • Kinlock, T.W.1    Gorden, M.S.2    Schwartz, R.P.3    Fitzgerald, T.T.4
  • 31
    • 0042360208 scopus 로고    scopus 로고
    • Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
    • 1:CAS:528:DC%2BD3sXntFeitrw%3D 12954743
    • Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949-58.
    • (2003) N Engl J Med , vol.349 , pp. 949-958
    • Fudala, P.J.1    Bridge, T.P.2    Herbert, S.3    Williford, W.O.4    Chiang, C.N.5    Jones, K.6
  • 32
    • 77955095276 scopus 로고    scopus 로고
    • Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians
    • 20598829
    • Arfken CL, Johanson CE, di Menza S, Schuster CR. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J Subst Abuse Treat. 2010;39:96-104.
    • (2010) J Subst Abuse Treat , vol.39 , pp. 96-104
    • Arfken, C.L.1    Johanson, C.E.2    Di Menza, S.3    Schuster, C.R.4
  • 33
    • 38149016864 scopus 로고    scopus 로고
    • The first three years of buprenorphine in the United States: Experience to date and future directions
    • 21768936
    • Fiellin DA. The first three years of buprenorphine in the United States: experience to date and future directions. J Addict Med. 2007;1:62-7.
    • (2007) J Addict Med , vol.1 , pp. 62-67
    • Fiellin, D.A.1
  • 34
    • 0027285893 scopus 로고
    • Barriers to treatment: Why alcohol and drug abusers delay or never seek treatment
    • 1:STN:280:DyaK3szktlSiug%3D%3D 8393611
    • Cunningham JA, Sobell LC, Sobell MB, Agrawal S, Toneatto T. Barriers to treatment: why alcohol and drug abusers delay or never seek treatment. Addict Behav. 1993;18:347-53.
    • (1993) Addict Behav , vol.18 , pp. 347-353
    • Cunningham, J.A.1    Sobell, L.C.2    Sobell, M.B.3    Agrawal, S.4    Toneatto, T.5
  • 35
    • 79951801129 scopus 로고    scopus 로고
    • Patients' reasons for choosing office-based buprenorphine: Preference for patient-centered care
    • 3002395 21170143
    • Korthuis PT, Gregg J, Rogers WE, McCarty D, Nicolaidis C, Boverman J. Patients' reasons for choosing office-based buprenorphine: preference for patient-centered care. J Addict Med. 2010;4:204-10.
    • (2010) J Addict Med , vol.4 , pp. 204-210
    • Korthuis, P.T.1    Gregg, J.2    Rogers, W.E.3    McCarty, D.4    Nicolaidis, C.5    Boverman, J.6
  • 36
    • 79952064014 scopus 로고    scopus 로고
    • Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance
    • 3527632 21053756
    • Awgu E, Magura S, Rosenblum A. Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance. J Psychoactive Drugs. 2010;42:339-46.
    • (2010) J Psychoactive Drugs , vol.42 , pp. 339-346
    • Awgu, E.1    Magura, S.2    Rosenblum, A.3
  • 37
    • 48249141077 scopus 로고    scopus 로고
    • Buprenorphine treatment in an urban community health center: What to expect
    • 2840630 18928077
    • Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, et al. Buprenorphine treatment in an urban community health center: what to expect. Fam Med. 2008;40:500-6.
    • (2008) Fam Med , vol.40 , pp. 500-506
    • Cunningham, C.1    Giovanniello, A.2    Sacajiu, G.3    Whitley, S.4    Mund, P.5    Beil, R.6
  • 39
    • 2342650165 scopus 로고    scopus 로고
    • Health promotion by social cognitive means
    • 15090118
    • Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31:143-64.
    • (2004) Health Educ Behav , vol.31 , pp. 143-164
    • Bandura, A.1
  • 41
    • 84893898519 scopus 로고    scopus 로고
    • Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program
    • 4012750 24481929
    • Shah PA, Sohler NL, Lopez C, Fox AD, Cunningham CO. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program. J Opioid Manag. 2013;9:407-13.
    • (2013) J Opioid Manag , vol.9 , pp. 407-413
    • Shah, P.A.1    Sohler, N.L.2    Lopez, C.3    Fox, A.D.4    Cunningham, C.O.5
  • 42
    • 79953163674 scopus 로고    scopus 로고
    • Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation
    • 3087632 21377275
    • Roman PM, Abraham AJ, Knudsen HK. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav. 2011;36:584-9.
    • (2011) Addict Behav , vol.36 , pp. 584-589
    • Roman, P.M.1    Abraham, A.J.2    Knudsen, H.K.3
  • 43
    • 84898718568 scopus 로고    scopus 로고
    • Confronting the stigma of opioid use disorder-and its treatment
    • 24577059
    • Olsen Y, Sharfstein JM. Confronting the stigma of opioid use disorder-and its treatment. JAMA. 2014;311:1393-4.
    • (2014) JAMA , vol.311 , pp. 1393-1394
    • Olsen, Y.1    Sharfstein, J.M.2
  • 44
    • 68449099636 scopus 로고    scopus 로고
    • Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users
    • 2838492 19705676
    • Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, et al. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users. J Psychoactive Drugs. 2009;41:145-52.
    • (2009) J Psychoactive Drugs , vol.41 , pp. 145-152
    • Mitchell, S.G.1    Kelly, S.M.2    Brown, B.S.3    Reisinger, H.S.4    Peterson, J.A.5    Ruhf, A.6
  • 45
    • 32244444572 scopus 로고    scopus 로고
    • Injectable, sustained-release naltrexone for the treatment of opioid dependence: A randomized, placebo-controlled trial
    • 1:CAS:528:DC%2BD28XhslWku7g%3D 4200530 16461865
    • Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63:210-8.
    • (2006) Arch Gen Psychiatry , vol.63 , pp. 210-218
    • Comer, S.D.1    Sullivan, M.A.2    Yu, E.3    Rothenberg, J.L.4    Kleber, H.D.5    Kampman, K.6
  • 46
    • 84882272987 scopus 로고    scopus 로고
    • Injectable extended-release naltrexone (XR-NTX) for opioid dependence: Long-term safety and effectiveness
    • 23701526
    • Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness. Addiction. 2013;108:1628-37.
    • (2013) Addiction , vol.108 , pp. 1628-1637
    • Krupitsky, E.1    Nunes, E.V.2    Ling, W.3    Gastfriend, D.R.4    Memisoglu, A.5    Silverman, B.L.6
  • 47
    • 23744463236 scopus 로고    scopus 로고
    • Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
    • 1646626 15899557
    • Hulse GK, Tait RJ, Comer SD, Sullivan MA, Jacobs IG, Arnold-Reed D. Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend. 2005;79:351-7.
    • (2005) Drug Alcohol Depend , vol.79 , pp. 351-357
    • Hulse, G.K.1    Tait, R.J.2    Comer, S.D.3    Sullivan, M.A.4    Jacobs, I.G.5    Arnold-Reed, D.6
  • 48
    • 47349122953 scopus 로고    scopus 로고
    • Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment
    • 17931824
    • Tait RJ, Ngo HT, Hulse GK. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment. J Subst Abuse Treat. 2008;35:116-24.
    • (2008) J Subst Abuse Treat , vol.35 , pp. 116-124
    • Tait, R.J.1    Ngo, H.T.2    Hulse, G.K.3
  • 49
    • 84856945762 scopus 로고    scopus 로고
    • A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers
    • 3365863 22263713
    • Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, et al. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus. 2012;33:48-59.
    • (2012) Subst Abus , vol.33 , pp. 48-59
    • Coviello, D.M.1    Cornish, J.W.2    Lynch, K.G.3    Boney, T.Y.4    Clark, C.A.5    Lee, J.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.